EU-LAC HEALTH · Defining a Roadmap for Cooperative Health research between the EU and Latin America-Caribbean countries: a Policy Oriented Approach

The EU-LAC Health coordinating action proposes to define a detailed plan to guide policy makers and other stakeholders on future actions to support cooperative Health Research between Latin America and Caribbean countries (LAC) and the European Commission and Member States (EU). This consensus Roadmap will be developed using a policy oriented approach and taking into account the new political framework for EU-LAC collaboration in S&T. The Roadmap will provide policy-makers and R&D funding bodies with new insights on how to best coordinate and fund cooperative health research between the two regions. An important effort will be devoted during the project to link and coordinate two important policy areas with strong involvement in health research funding: Science and technology policy (research) and International development cooperation.EU-LAC Health will have as main goals to:a) Discuss and explore, with policy-makers and other stakeholders, how to best coordinate health research policies and funding between EU and LAC.b) Establish a consensus Roadmap for cooperative health research with the final objective of setting up a future framework for collaboration between the EU and LAC regions in this field.c) Disseminate the project results to the main project stakeholders as a means to increase and improve EU-LAC cooperation in health research.The project is planned as a 5 year Support Action, carried out by a consortium of 8 participants from Spain, Switzerland/Mexico, Argentina, Costa Rica, Brazil, Italy and Germany. The selected institutions form a multidisciplinary team with participants from Health Research policy-making Institutions, R&D Funding Agencies, Research Centers, and specialized R&D consulting companies. The project will benefit from a direct participation of main stakeholders from policy making and funding institutions involved in EU LAC health research, as members of the advisory board and a high level expert group.